InsidersTradesSigma
Explore the full record of transactions filed by Broder Samuel, 董事. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. Aggregated, 1 disclosures have been published. Activity tracked since 10 June 2022. The latest transaction was disclosed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Samuel Broder is a Board Member at Sensei Biotherapeutics, Inc. He plays a key role in the strategic direction of the company, contributing to policy development and operational oversight. His expertise in the biopharmaceutical field is essential in guiding the organization's innovation and growth.